SARS-CoV-2 疫苗在血液系统恶性肿瘤患者中的疗效：进一步研究的实用要点。
SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research.
机构信息
Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
出版信息
Oncologist. 2022 Nov 3;27(11):e917-e918. doi: 10.1093/oncolo/oyac173.
PMID:36005823
Abstract
This letter to the editor responds to comments on a recently published article on seroconversion rates after COVID-19 vaccination.
摘要
这封给编辑的信是对最近发表的一篇关于 COVID-19 疫苗接种后血清转化率的文章的评论的回应。
Zotero 插件